SCHEMBL6968819

SCHEMBL6968819

CC1(C)CCN(CCCN)C(c2ccccc2)(c2ccccc2)C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 3/20 0.41
DRD4 P21917 1/20 0.41
SIGMAR1 Q99720 2/20 0.38
CYP2D6 P10635 1/20 0.38
HTR2A P28223 1/20 0.36
MAOA P21397 1/20 0.34
MAOB P27338 1/20 0.34
TAAR1 Q96RJ0 1/20 0.34
GRIN1 Q05586 3/20 0.34
GRIN2A Q12879 3/20 0.34
GRIN2D O15399 2/20 0.34
GRIN3B O60391 2/20 0.34
GRIN2B Q13224 2/20 0.34
GRIN2C Q14957 2/20 0.34
GRIN3A Q8TCU5 2/20 0.34
GRIA1 P42261 1/20 0.34
GRIA2 P42262 1/20 0.34
GRIA3 P42263 1/20 0.34
GRIA4 P48058 1/20 0.34
CHRM2 P08172 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10337083 0.74 OPRM1 (0.46) OPRM1DRD4SIGMAR1CYP2D6GRIN1
SCHEMBL8611359 0.73 DRD2 (0.50) SIGMAR1
SCHEMBL6686824 0.70 SIGMAR1 (0.53) SIGMAR1CYP2D6
SCHEMBL27469704 0.68 SIGMAR1 (0.50) OPRM1DRD4SIGMAR1CYP2D6
SCHEMBL6195779 0.67 SIGMAR1 (0.57) OPRM1DRD4SIGMAR1CYP2D6GRIN1
SCHEMBL6197204 0.67 OPRM1 (0.37) OPRM1GRIN1GRIN2A
SCHEMBL3862428 0.66 GRIN1 (0.44) OPRM1DRD4SIGMAR1CYP2D6GRIN1
Propylamine SCHEMBL8638613 0.66 ADRA1A (0.53) OPRM1DRD4SIGMAR1CYP2D6GRIN1
SCHEMBL7242386 0.64 OPRM1 (0.51) OPRM1SIGMAR1CYP2D6
SCHEMBL7233756 0.64 SIGMAR1 (0.70) SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6620815-B1 Selective antagonists for human alpha 1A receptors; benign prostatic hyperplasia, impotency, cardiac arrhythmia treatment; anticholesterol agents; intraocular pressure reduction SYNAPTIC PHARMACEUTICAL CORPORATION 2003-09-16 US disclosed
EP-0988295-A4 HETEROCYCLIC SUBSTITUTED PIPERIDINES AND USES THEREOF SYNAPTIC PHARMA CORP (US) 2003-08-13 EP disclosed
EP-1140876-A1 MORPHOLINONE AND MORPHOLINE DERIVATIVES AND USES THEREOF SYNAPTIC PHARMACEUTICAL CORPORATION (US) 2001-10-10 EP disclosed
US-6159990-A Oxazolidinones as α1A receptor antagonists SYNAPTIC PHARMACEUTICAL CORPORATION (US) 2000-12-12 US disclosed
WO-2000035891-A1 MORPHOLINONE AND MORPHOLINE DERIVATIVES AND USES THEREOF SYNAPTIC PHARMACEUTICAL CORPORATION (US) 2000-06-22 WO disclosed
EP-0988295-A1 HETEROCYCLIC SUBSTITUTED PIPERIDINES AND USES THEREOF SYNAPTIC PHARMACEUTICAL CORPORATION (US) 2000-03-29 EP disclosed
WO-1998057940-A1 HETEROCYCLIC SUBSTITUTED PIPERIDINES AND USES THEREOF SYNAPTIC PHARMACEUTICAL CORPORATION (US) 1998-12-23 WO disclosed
WO-1998051311-A2 DIHYDROPYRIMIDINES AND USES THEREOF SYNAPTIC PHARMACEUTICAL CORPORATION (US) 1998-11-19 WO disclosed